These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 11912497)

  • 1. Human Toll-like receptor 4 recognizes host-specific LPS modifications.
    Hajjar AM; Ernst RK; Tsai JH; Wilson CB; Miller SI
    Nat Immunol; 2002 Apr; 3(4):354-9. PubMed ID: 11912497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/MD-1.
    Miyake K; Ogata H; Nagai Y; Akashi S; Kimoto M
    J Endotoxin Res; 2000; 6(5):389-91. PubMed ID: 11521060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of TLR4/MD-2 complex in species-specific lipopolysaccharide-mimetic signal transduction by Taxol.
    Kawasaki K; Akashi S; Shimazu R; Yoshida T; Miyake K; Nishijima M
    J Endotoxin Res; 2001; 7(3):232-6. PubMed ID: 11581576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential role of MD-2 in LPS responsiveness and TLR4 distribution.
    Nagai Y; Akashi S; Nagafuku M; Ogata M; Iwakura Y; Akira S; Kitamura T; Kosugi A; Kimoto M; Miyake K
    Nat Immunol; 2002 Jul; 3(7):667-72. PubMed ID: 12055629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MD-2 binds to bacterial lipopolysaccharide.
    Viriyakosol S; Kirkland T; Soldau K; Tobias P
    J Endotoxin Res; 2000; 6(6):489-91. PubMed ID: 11521076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance.
    Calvano JE; Agnese DM; Um JY; Goshima M; Singhal R; Coyle SM; Reddell MT; Kumar A; Calvano SE; Lowry SF
    Shock; 2003 Nov; 20(5):415-9. PubMed ID: 14560104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa lipid A diversity and its recognition by Toll-like receptor 4.
    Ernst RK; Hajjar AM; Tsai JH; Moskowitz SM; Wilson CB; Miller SI
    J Endotoxin Res; 2003; 9(6):395-400. PubMed ID: 14733728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization.
    Saitoh S; Akashi S; Yamada T; Tanimura N; Kobayashi M; Konno K; Matsumoto F; Fukase K; Kusumoto S; Nagai Y; Kusumoto Y; Kosugi A; Miyake K
    Int Immunol; 2004 Jul; 16(7):961-9. PubMed ID: 15184344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for lipopolysaccharide mimetic action of Taxol and flavolipin.
    Kawasaki K; Gomi K; Kawai Y; Shiozaki M; Nishijima M
    J Endotoxin Res; 2003; 9(5):301-7. PubMed ID: 14577846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of endotoxins with Toll-like receptor 4 correlates with their endotoxic potential and may explain the proinflammatory effect of Brucella spp. LPS.
    Dueñas AI; Orduña A; Crespo MS; García-Rodríguez C
    Int Immunol; 2004 Oct; 16(10):1467-75. PubMed ID: 15339879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Toll-like receptor 4 region Glu24-Pro34 is critical for interaction with MD-2.
    Nishitani C; Mitsuzawa H; Hyakushima N; Sano H; Matsushima N; Kuroki Y
    Biochem Biophys Res Commun; 2005 Mar; 328(2):586-90. PubMed ID: 15694388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human MD-2 discrimination of meningococcal lipid A structures and activation of TLR4.
    Zimmer SM; Zughaier SM; Tzeng YL; Stephens DS
    Glycobiology; 2007 Aug; 17(8):847-56. PubMed ID: 17545685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Functional roles of TLR4/MD-2 and RP105/MD-1 in innate recognition of LPS].
    Kusumoto Y; Miyake K
    Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2103-8. PubMed ID: 12518421
    [No Abstract]   [Full Text] [Related]  

  • 14. LPS, TLR4 and infectious disease diversity.
    Miller SI; Ernst RK; Bader MW
    Nat Rev Microbiol; 2005 Jan; 3(1):36-46. PubMed ID: 15608698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of truncated human lipopolysaccharide-binding protein in Escherichia coli.
    Kohara J; Tsuneyoshi N; Gauchat JF; Kimoto M; Fukudome K
    Protein Expr Purif; 2006 Oct; 49(2):276-83. PubMed ID: 16839777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation between toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from gram-negative and gram-positive bacteria.
    Laflamme N; Echchannaoui H; Landmann R; Rivest S
    Eur J Immunol; 2003 Apr; 33(4):1127-38. PubMed ID: 12672079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role of MD-2 in B-cell responses to lipopolysaccharide and Toll-like receptor 4 distribution.
    Miyake K; Nagai Y; Akashi S; Nagafuku M; Ogata M; Kosugi A
    J Endotoxin Res; 2002; 8(6):449-52. PubMed ID: 12697088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of LPS-binding peptide fragment of MD-2, a toll-receptor accessory protein.
    Mancek M; Pristovsek P; Jerala R
    Biochem Biophys Res Commun; 2002 Apr; 292(4):880-5. PubMed ID: 11944896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4.
    Pålsson-McDermott EM; O'Neill LA
    Immunology; 2004 Oct; 113(2):153-62. PubMed ID: 15379975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
    Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
    Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.